| __timestamp | Celldex Therapeutics, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 101881000 | 9216000000 |
| Thursday, January 1, 2015 | 4011000 | 8296000000 |
| Friday, January 1, 2016 | 102026000 | 10044000000 |
| Sunday, January 1, 2017 | 96171000 | 11560000000 |
| Monday, January 1, 2018 | 66449000 | 10558000000 |
| Tuesday, January 1, 2019 | 42672000 | 9351000000 |
| Wednesday, January 1, 2020 | 42534000 | 8933000000 |
| Friday, January 1, 2021 | 3068000 | 8284000000 |
| Saturday, January 1, 2022 | 1400000 | 7952000000 |
| Sunday, January 1, 2023 | 3008000 | 8200000000 |
| Monday, January 1, 2024 | 8480000000 |
Cracking the code
In the pharmaceutical industry, cost management is crucial for sustaining profitability. This chart compares the cost of revenue for Teva Pharmaceutical Industries Limited and Celldex Therapeutics, Inc. from 2014 to 2023. Teva, a global leader, consistently reported costs around 9 billion USD annually, peaking in 2017 with a 25% increase from 2014. In contrast, Celldex, a smaller biotech firm, showed more volatility, with costs fluctuating between 1 million and 102 million USD. Notably, Celldex's costs dropped by over 95% from 2014 to 2022, reflecting strategic shifts or operational efficiencies. This comparison highlights the diverse financial landscapes within the pharmaceutical sector, where scale and strategy significantly impact cost structures. Understanding these dynamics is essential for investors and stakeholders aiming to navigate the complexities of the industry.
Cost of Revenue Trends: AstraZeneca PLC vs Celldex Therapeutics, Inc.
Cost of Revenue Trends: Zoetis Inc. vs Teva Pharmaceutical Industries Limited
Regeneron Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Corcept Therapeutics Incorporated
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Cytokinetics, Incorporated
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Alkermes plc's Expenses
Comparing Cost of Revenue Efficiency: Halozyme Therapeutics, Inc. vs Celldex Therapeutics, Inc.
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs Celldex Therapeutics, Inc.
Cost of Revenue Trends: Perrigo Company plc vs Celldex Therapeutics, Inc.
Cost of Revenue Trends: Veracyte, Inc. vs Celldex Therapeutics, Inc.
Cost of Revenue Comparison: MorphoSys AG vs Celldex Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Celldex Therapeutics, Inc. vs Dyne Therapeutics, Inc.